Circulating inflammation markers and risk of epithelial ovarian cancer
about
Seminal Fluid-Mediated Inflammation in Physiology and Pathology of the Female Reproductive TractThe association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanismsStress induced premature senescence: a new culprit in ovarian tumorigenesis?Targeted immune therapy of ovarian cancerDietary inflammatory index and risk of epithelial ovarian cancer in African American women.Augmented Serum Amyloid A1/2 Mediated by TNF-induced NF-κB in Human Serous Ovarian Epithelial Tumors.Cytokine and chemokine patterns across 100 days after hematopoietic stem cell transplantation in children.Protective Effect of Progesterone during Pregnancy against Ovarian Cancer.Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer.Application of proteomics to cancer early detectionFactors associated with inflammation markers, a cross-sectional analysis.Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC CohortOptimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.BRCA1 185delAG Mutation Enhances Interleukin-1β Expression in Ovarian Surface Epithelial Cells.A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE II.The Role of Cathelicidin LL-37 in Cancer Development.A prospective study of leisure-time physical activity and risk of incident epithelial ovarian cancer: Impact by menopausal status.Partially Linear Single Index Cox Regression Model in Nested Case-Control Studies.Circulating prolactin levels and risk of epithelial ovarian cancer.Endometriosis-associated ovarian cancer: a review of pathogenesisA prospective study of phobic anxiety, risk of ovarian cancer, and survival among patientsOvarian cancer risk factors by tumor dominance, a surrogate for cell of originCortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer.Estimation and selection of complex covariate effects in pooled nested case-control studies with heterogeneity.Circulating interleukin-8 and plasminogen activator inhibitor-1 are increased in women with ovarian carcinoma.Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer.The immune system in the pathogenesis of ovarian cancer.Current state of biomarkers in ovarian cancer prognosis.Obesity and Ovarian Cancer.Wnt5A exerts immunomodulatory activity in the human ovarian cancer cell line SKOV-3.Host factors associated with serologic inflammatory markers assessed using multiplex assays.The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor MicroenvironmentThe metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role.PRKCI promotes immune suppression in ovarian cancer.Human cytomegalovirus in high grade serous ovarian cancer possible implications for patients survival.Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer
P2860
Q26742070-616E2544-380C-4313-8C9F-023E2FE81455Q27026813-8FD60225-EEF1-4C3B-87F2-2B00F4DCC6A0Q28081246-E0EAAC99-3C26-4B36-88F9-D8416476FC42Q28082828-465D96A4-D3A9-43DA-87E5-9CDDC0453537Q30275751-383E7E3F-9787-494D-B4DA-EFD92ADD2669Q33611319-F909BE15-7054-442E-BFDB-FF4324BB2ACEQ34148885-5D75CD6D-CA2B-4294-873B-E2EDBAA11479Q34305384-D44BC206-5AD5-4894-9117-1549FB18993BQ34624404-3161D945-03A6-4BDC-A8D1-92A6912B7D69Q35007052-68827C03-667D-457B-A5F5-E4D39E9BF6D1Q35053031-F50F95B3-FC02-4583-9B47-CDD64619CF7EQ35633792-3F09B4AA-2D83-4F09-A3DC-D4FC14A42A51Q35680361-D3794C26-768F-4153-91B4-CF0E93D2D1FEQ35837949-4E85660D-680E-46EB-AA1C-A74B06C212E3Q36017531-FAD8A152-38F3-4AD8-B8B7-E3EC163BB794Q36288241-A166908F-D79F-4DC8-9E9A-F34C43E32B9EQ36465085-148F9036-1ACB-4B35-A1D2-79F4EB8B6FB0Q36469876-E3E1ED59-2D54-43C6-A90A-C2A9A1441F12Q36481424-C3AB476D-6C66-43D5-B52D-A0C57F763005Q36698788-D5E340B8-45F3-47D5-A11E-4AA5DF0CD595Q36790454-BF451E3F-D05C-4310-B243-C65C1E6DF6F0Q36823174-C62293CB-0D70-44C6-8680-C39457C78CB4Q36948873-92938B11-0993-4465-BE3C-42C03812BD5AQ36971577-2700FFEF-9750-4A12-9AAC-FBF3D9E7FA66Q37220800-02925069-D6CE-4877-8D68-F264D101CA13Q37344971-19CFE95E-1D10-47F2-A3F5-EF553F7BBBDEQ37390397-20209D8F-76BD-4EC9-A030-8F7DC11A959FQ37409359-C5ABEF69-198A-4E67-B056-448817FBFA19Q37613407-715AEBB5-5507-4BCF-907D-43FFE718DE5CQ38628964-B495C6E2-2E48-4D9F-8EEE-2011C6362BB1Q38788240-7D9F21AC-197D-45EF-BDFB-1BCC5D8A7E21Q38828227-3132A11C-D7F7-4146-BAA8-2F0D1EE3BA10Q40704505-4A90021D-19E1-4DB5-9A20-BE7EE5906ECBQ41341695-E0CF6619-D5A5-4753-9AE1-93E26857E03CQ46304569-BE9C67AF-2F00-4A52-96A1-6D32FAFFFBB5Q47154650-5ECF4C25-4C3C-4631-8012-5DBF4149958AQ47548990-822A4C77-8B9D-4600-8C08-BFF396A23265Q58423073-38C50A23-AD1F-439A-8942-5A6BE33A6E00
P2860
Circulating inflammation markers and risk of epithelial ovarian cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Circulating inflammation markers and risk of epithelial ovarian cancer
@ast
Circulating inflammation markers and risk of epithelial ovarian cancer
@en
Circulating inflammation markers and risk of epithelial ovarian cancer
@nl
type
label
Circulating inflammation markers and risk of epithelial ovarian cancer
@ast
Circulating inflammation markers and risk of epithelial ovarian cancer
@en
Circulating inflammation markers and risk of epithelial ovarian cancer
@nl
prefLabel
Circulating inflammation markers and risk of epithelial ovarian cancer
@ast
Circulating inflammation markers and risk of epithelial ovarian cancer
@en
Circulating inflammation markers and risk of epithelial ovarian cancer
@nl
P2093
P2860
P50
P1476
Circulating inflammation markers and risk of epithelial ovarian cancer
@en
P2093
Adele Marrangoni
Alan A Arslan
Anna E Lokshin
Annika Idahl
Brian M Nolen
Franco Berrino
Karen L Koenig
Mengling Liu
Nina Ohlson
Paola Muti
P2860
P304
P356
10.1158/1055-9965.EPI-10-1180
P50
P577
2011-04-05T00:00:00Z